Literature DB >> 27099661

Post dengue neurological complication.

A H Hasliza1, H Tohid2, K Y Loh3, P Santhi4.   

Abstract

Dengue infection is highly endemic in many tropical countries including Malaysia. However, neurological complications arising from dengue infection is not common; Gullain-Barre syndrome (GBS) is one of these infrequent complications. In this paper, we have reported a case in which a 39-year-old woman presented with a neurological complication of dengue infection without typical symptoms and signs of dengue fever. She had a history of acute gastroenteritis (AGE) followed by an upper respiratory tract infection (URTI) weeks prior to her presentation rendering GBS secondary to the post viral URTI and AGE as the most likely diagnosis. Presence of thrombocytopenia was the only clue for dengue in this case.

Entities:  

Year:  2015        PMID: 27099661      PMCID: PMC4826581     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  13 in total

Review 1.  Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Hans-Peter Hartung
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

2.  Guillain-Barre syndrome occurring in the course of dengue fever.

Authors:  Sudhir Kumar; Subhashini Prabhakar
Journal:  Neurol India       Date:  2005-06       Impact factor: 2.117

3.  Oligosymptomatic dengue infection: a potential cause of Guillain Barré syndrome.

Authors:  Cristiane Nascimento Soares; Mauro Cabral-Castro; Celina Oliveira; Luis Claudio Faria; José Mauro Peralta; Marcos Raimundo Gomes de Freitas; Marzia Puccioni-Sohler
Journal:  Arq Neuropsiquiatr       Date:  2008-06       Impact factor: 1.420

4.  Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis.

Authors:  C N Soares; L C Faria; J M Peralta; M R G de Freitas; M Puccioni-Sohler
Journal:  J Neurol Sci       Date:  2006-07-25       Impact factor: 3.181

5.  Evaluation of platelets as predictive parameters in dengue Fever.

Authors:  K Jayashree; G C Manasa; P Pallavi; G V Manjunath
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-20       Impact factor: 0.900

Review 6.  Neurological complications in dengue infection: a review for clinical practice.

Authors:  Marzia Puccioni-Sohler; Carolina Rosadas; Mauro Jorge Cabral-Castro
Journal:  Arq Neuropsiquiatr       Date:  2013-09       Impact factor: 1.420

7.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

Authors:  Christiaan Fokke; Bianca van den Berg; Judith Drenthen; Christa Walgaard; Pieter Antoon van Doorn; Bart Casper Jacobs
Journal:  Brain       Date:  2013-10-26       Impact factor: 13.501

8.  Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells.

Authors:  Rajas V Warke; Aniuska Becerra; Agatha Zawadzka; Diane J Schmidt; Katherine J Martin; Kris Giaya; Jonathan H Dinsmore; Marcia Woda; Gregory Hendricks; Tracy Levine; Alan L Rothman; Irene Bosch
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

Review 9.  Neurological complications of dengue virus infection.

Authors:  Francisco Javier Carod-Artal; Ole Wichmann; Jeremy Farrar; Joaquim Gascón
Journal:  Lancet Neurol       Date:  2013-09       Impact factor: 44.182

10.  Neurological complications of dengue fever: Experience from a tertiary center of north India.

Authors:  Rajesh Verma; Pawan Sharma; Ravindra Kumar Garg; Veerendra Atam; Maneesh Kumar Singh; Hardeep Singh Mehrotra
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

View more
  1 in total

1.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.